Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab Add-on to Gemcitabine/S-1 in Metastatic Pancreatic Cancer
NCT04377048Phase 2Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Jul 2020
- Primary completion
- Jul 2022
01
Overview
A Phase 2 trial of nivolumab in pancreatic adenocarcinoma (PDAC), sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT04377048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04377048.